Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Matrix Biology : Journal of the International Society for Matrix Biology|December 13, 2024
Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint diseaseRens de Groot, Patricia Badía Folgado, Kazuhiro Yamamoto, et al.Annals of the Rheumatic Diseases|March 5, 2022
Osteoarthritis endotype discovery via clustering of biochemical marker dataFederico Angelini, Paweł Widera, Ali Mobasheri, et al.RMD Open|December 16, 2021
Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: prevalence and phenotypingEefje Martine van Helvoort, Paco M J Welsing, Mylène P Jansen, et al.Osteoarthritis and Cartilage|November 10, 2024
Longitudinal stability of molecular endotypes of knee osteoarthritis patientsMonica T Hannani, Christian S Thudium, Alfred C Gellhorn, et al.Rheumatology (Oxford, England)|May 16, 2022
Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohortEefje M van Helvoort, Mylène P Jansen, Anne C A Marijnissen, et al.Osteoarthritis and Cartilage Open|August 31, 2023
Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH studyPaweł Widera, Paco M J Welsing, Samuel O Danso, et al.BMJ Open|July 30, 2020
Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markersEefje M van Helvoort, Willem E van Spil, Mylène P Jansen, et al.Journal of Medicinal Chemistry|August 16, 2012
Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT)Hongfeng Deng, Heather O'Keefe, Christopher P Davie, et al.Science Translational Medicine|November 9, 2012
An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failureKevin S Thorneloe, Mui Cheung, Weike Bao, et al.Pageof 2